The Food and Drug Administration has approved apremilast (Otezla, Celgene) for the treatment of adult patients with moderate-to-severe plaque psoriasis, the second approval for the drug this year. » Read more
A new study suggests the combination therapy of afamelanotide implant and narrowband ultraviolet B (NB-UVB) phototherapy is more effective than NB-UVB therapy alone in treating vitiligo. » Read the study results
People with longer telomeres may have a 30 percent higher risk of contracting melanoma, according to results of a recent international study. » See the findings
There is a significant gap or lack of understanding on the part of the medical community surrounding the potential benefits associated with online search and social media, leading to unfounded fears and reluctance to participate. » See why to get involved
Like
Tweet
